Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Post by Horn1369on Jun 02, 2016 11:39am
105 Views
Post# 24927092

Western Producer Editorial from yesterday

Western Producer Editorial from yesterday

Canada must better meet demand for health products

Plant a seed but don’t allow the plant to grow. Encourage innovation but don’t provide the climate in which it can flourish.

Sounds perverse, doesn’t it?

Yet it is happening in Canada because of outdated regulations governing new livestock feed additives.

Ottawa-based life sciences company Avivagen finds itself in this very situation. It has developed a product that shows potential to replace at least some of the antibiotics that are now used in livestock feed to prevent illness and promote growth.

Invented in Canada, using taxpayers’ money, at least in part, the additive called OxC-beta is not registered in Canada. Avivagen president Cameron Groome is doubtful it ever will be under current Health Canada and Canadian Food Inspection Agency regulations.

There are global concerns about antibiotic resistant bacteria and the role that antimicrobial use in livestock production might play.

 

Countries, including Canada, are either taking or considering steps to limit antibiotic use in livestock.

So, this seems the ideal time to explore alternatives that will protect animal health, food production and Canadian livestock industry competitiveness.

Cattle, hog and poultry producers in Canada all acknowledge the challenge and are taking steps to address it. Most recently, the Beef Cattle Research Council announced a research strategy that, in part, focuses on finding “nutritional management strategies” to reduce the need for antibiotics.

However, while several Asian countries, having tested OxC-beta, are in the process of regulating it for livestock use, such is not the case in Canada.

Avivagen’s product is only one illustration of how innovation can be stymied even as it tries to address a pressing global trend. There are likely other products in a similar position, with and without the peer-reviewed studies and research that this one appears to have.

 

Without reasonable expectations of regulatory approval, innovators can’t be blamed for launching their products elsewhere, leaving Canadian producers without access.

We do not suggest that Canada should lower the bar when it comes to testing livestock feed products for safety and efficacy. This country has its reputation for safe food in large part because of its regulations.

However, there are excellent reasons to modernize the rules as times change and new scenarios present themselves. The feed regulations have seen various modifications over the years, but they haven’t been truly overhauled since the 1980s.

Fortunately, the CFIA has undertaken modernization of these regulations, a process that began in 2012 and may be ready for public consultation in winter 2017.

Among potential changes are greater flexibility to consider information from product registration in other countries and improvements to the registration application process.

 

Those changes could better and more swiftly recognize technological change and innovation within the livestock feed realm. Canadian livestock producers will hope so. In fact, they will demand it.

Bruce Dyck, Terry Fries, Barb Glen, Brian MacLeod and D’Arce McMillan collaborate in the writing of Western Producer editorials.

From: https://www.avivagen.com/media_coverage/the-western-producer-canada-must-better-meet-demand-for-health-products/


Bullboard Posts